Health
Biotechnology
Pharmaceutical

Ionis Pharmaceuticals

$70.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.13 (4.64%) As of 2:56 PM EDT today
+$3.13 (4.64%) Today

Why Robinhood?

You can buy or sell IONS and other stocks, options, ETFs, and crypto commission-free!

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. Read More The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Employees
737
Headquarters
Carlsbad, California
Founded
1989
Market Cap
9.41B
Price-Earnings Ratio
27.20
Dividend Yield
0.00
Average Volume
861.82K
High Today
$70.83
Low Today
$67.31
Open Price
$67.31
Volume
893.50K
52 Week High
$86.58
52 Week Low
$41.25

Collections

Health
Biotechnology
Pharmaceutical
Therapy
Technology

IONS Earnings

-$0.17
$0.09
$0.36
$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected Aug 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.